Therefore, the novel Pim kinase inhibitor DHPCC-9 is not only an efficient tool for Pim research, but also a promising compound for cancer drug development and could be targeted especially to inhibit invasiveness of Pim-overexpressing cancer cells. Here, PIM1 is linked to cancer.